FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Vet Intern Med / Cardiac troponin I as compared to troponin T for the detecti...
Journal of veterinary internal medicine2015; 29(1); 348-354; doi: 10.1111/jvim.12530

Cardiac troponin I as compared to troponin T for the detection of myocardial damage in horses.

Abstract: Different cardiac troponin I (cTnI) assays give different results. Only 1 manufacturer has marketed troponin T (cTnT) assays. Therefore, cTnT often is preferred for detection of myocardial infarction in human patients. Studies of cTnT in horses are limited. Objective: To compare a cTnI and a high-sensitive cTnT assay (hs-cTnT) in horses. Methods: Cardiac troponin I and cTnT were determined in 35 healthy horses (group 1), 23 horses suspected to have primary myocardial damage (group 2a), and 41 horses with secondary myocardial damage caused by structural heart disease (group 2b). Methods: All cTnI samples were analyzed at laboratory A (limit of detection [LOD]: 0.03 ng/mL), whereas cTnT samples were analyzed at 2 laboratories with the same hs-cTnT assay (laboratory B, LOD: 10.0 pg/mL; laboratory C, LOD: 4.0 pg/mL). Results: The median cTnI concentration in group 2a (0.90 ng/mL; range, 0.03-58.27 ng/mL) was significantly higher (P < .001) than in group 1 (0.03 ng/mL; range, 0.03-0.09 ng/mL) or group 2b (0.05 ng/mL; range, 0.03-30.92 ng/mL), and the optimal cut-off for detection of primary myocardial damage was 0.095 ng/mL (sensitivity: 90.5%, specificity: 100%). Using an LOD of 10.0 pg/mL for all cTnT samples, a cut-off value of 10.5 pg/mL was found, but sensitivity was low (42.9%). When only samples analyzed at laboratory C (n = 58) were included, a cut-off of 6.6 pg/mL was found (sensitivity: 81%, specificity: 100%). Conclusions: Despite large quantitative differences, cTnI and cTnT are both useful for detection of myocardial damage in horses.
Copyright © 2015 by the American College of Veterinary Internal Medicine.
Get Full Text
Publication Date: 2015-01-27 PubMed ID: 25619522PubMed Central: PMC4858065DOI: 10.1111/jvim.12530Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The paper explores the effectiveness of using cardiac Troponin I (cTnI) and high-sensitive cTnT assays in detecting myocardial damage in horses. It finds that while there are significant variations in the results, both cTnI and cTnT are useful for detecting this type of damage in horses.

Objective and Methods

The paper’s primary objective was to compare a cardiac troponin I (cTnI) and a high-sensitive troponin T (hs-cTnT) assay in horses. It was recognized that different manufacturers produced cTnI and only one produced cTnT. The study involved:

  • Determining cTnI and cTnT in 35 healthy horses (group 1), 23 horses suspected of having primary myocardial damage (group 2a), and 41 horses with secondary myocardial damage due to structural heart disease (group 2b).
  • Analysing all cTnI samples at one laboratory (lab A), while cTnT samples were examined at two different labs (lab B and lab C) using the same hs-cTnT assay.

Results

The results obtained in the study were:

  • The median cTnI concentration in group 2a was significantly higher than in group 1 or group 2b. However, both cTnI and cTnT proved useful in detecting myocardial damage in horses.
  • An optimal cTnI cut-off for detecting primary myocardial damage was 0.095 ng/mL with a high sensitivity (90.5%) and specificity (100%).
  • The use of cTnT with a limit of detection (LOD) of 10.0 pg/mL yielded a low sensitivity (42.9%), and an optimal cut-off value of 10.5 pg/mL was found.
  • When cTnT samples analysed exclusively at laboratory C were considered, a cut-off of 6.6 pg/mL was identified, with sensitivity of 81% and specificity of 100%.

The paper, therefore, concludes that despite significant quantitative differences in the results obtained using cTnI and cTnT, both are useful in detecting myocardial damage in horses.

Significance of the Study

This study is crucial for anyone involved in equine healthcare as it provides valuable information regarding the use of cTnI and cTnT as markers of myocardial damage in horses. While the sensitivity and specificity of these markers can vary depending on laboratory conditions, both have been shown to be effective tools in diagnosing myocardial injury, meaning they could play a key role in both the detection and subsequent treatment of cardiovascular diseases among horses.

Cite This Article

APA
Van Der Vekens N, Decloedt A, Ven S, De Clercq D, van Loon G. (2015). Cardiac troponin I as compared to troponin T for the detection of myocardial damage in horses. J Vet Intern Med, 29(1), 348-354. https://doi.org/10.1111/jvim.12530

Publication

Journal of veterinary internal medicine
ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 29
Issue: 1
Pages: 348-354

Researcher Affiliations

Van Der Vekens, N
  • Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.
Decloedt, A
    Ven, S
      De Clercq, D
        van Loon, G

          MeSH Terms

          • Animals
          • Biomarkers
          • Echocardiography / veterinary
          • Electrocardiography / veterinary
          • Female
          • Heart Diseases / diagnosis
          • Heart Diseases / metabolism
          • Heart Diseases / pathology
          • Heart Diseases / veterinary
          • Horse Diseases / blood
          • Horse Diseases / diagnosis
          • Horses
          • Male
          • Myocardium / metabolism
          • Myocardium / pathology
          • Troponin I / blood
          • Troponin T / blood

          References

          This article includes 27 references
          1. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, Lindahl B, Giannitsis E, Hasin Y, Galvani M, Tubaro M, Alpert JS, Biasucci LM, Koenig W, Mueller C, Huber K, Hamm C, Jaffe AS. Recommendations for the use of cardiac troponin measurement in acute cardiac care.. Eur Heart J 2010 Sep;31(18):2197-204.
            pubmed: 20685679doi: 10.1093/eurheartj/ehq251google scholar: lookup
          2. Penttilä I, Penttilä K, Rantanen T. Laboratory diagnosis of patients with acute chest pain.. Clin Chem Lab Med 2000 Mar;38(3):187-97.
            pubmed: 10905753doi: 10.1515/cclm.2000.027google scholar: lookup
          3. Maynard SJ, Menown IB, Adgey AA. Troponin T or troponin I as cardiac markers in ischaemic heart disease.. Heart 2000 Apr;83(4):371-3.
            pmc: PMC1729379pubmed: 10722528doi: 10.1136/heart.83.4.371google scholar: lookup
          4. Apple FS, Saenger AK. The state of cardiac troponin assays: looking bright and moving in the right direction.. Clin Chem 2013 Jul;59(7):1014-6.
            pubmed: 23592505doi: 10.1373/clinchem.2013.203307google scholar: lookup
          5. Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury.. CMAJ 2005 Nov 8;173(10):1191-202.
            pmc: PMC1277047pubmed: 16275971doi: 10.1503/cmaj/051291google scholar: lookup
          6. O'Brien PJ, Landt Y, Ladenson JH. Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay.. Clin Chem 1997 Dec;43(12):2333-8.
            pubmed: 9439451
          7. O'Brien PJ, Dameron GW, Beck ML, Brandt M. Differential reactivity of cardiac and skeletal muscle from various species in two generations of cardiac troponin-T immunoassays.. Res Vet Sci 1998 Sep-Oct;65(2):135-7.
            pubmed: 9839891doi: 10.1016/s0034-5288(98)90164-3google scholar: lookup
          8. Schwarzwald CC, Hardy J, Buccellato M. High cardiac troponin I serum concentration in a horse with multiform ventricular tachycardia and myocardial necrosis.. J Vet Intern Med 2003 May-Jun;17(3):364-8.
            pubmed: 12774982
          9. Phillips W, Giguère S, Franklin RP, Hernandez J, Adin D, Peloso JG. Cardiac troponin I in pastured and race-training Thoroughbred horses.. J Vet Intern Med 2003 Jul-Aug;17(4):597-9.
            pubmed: 12892316doi: 10.1111/j.1939-1676.2003.tb02486.xgoogle scholar: lookup
          10. Kraus MS, Jesty SA, Gelzer AR, Ducharme NG, Mohammed HO, Mitchell LM, Soderholm LV, Divers TJ. Measurement of plasma cardiac troponin I concentration by use of a point-of-care analyzer in clinically normal horses and horses with experimentally induced cardiac disease.. Am J Vet Res 2010 Jan;71(1):55-9.
            pubmed: 20043781doi: 10.2460/ajvr.71.1.55google scholar: lookup
          11. Nostell K, Häggström J. Resting concentrations of cardiac troponin I in fit horses and effect of racing.. J Vet Cardiol 2008 Dec;10(2):105-9.
            pubmed: 19019757doi: 10.1016/j.jvc.2008.10.001google scholar: lookup
          12. Nath LC, Anderson GA, Hinchcliff KW, Savage CJ. Serum cardiac troponin I concentrations in horses with cardiac disease.. Aust Vet J 2012 Sep;90(9):351-7.
            pubmed: 22928683doi: 10.1111/j.1751-0813.2012.00970.xgoogle scholar: lookup
          13. Slack J, Boston RC, Soma L, Reef VB. Cardiac troponin I in racing standardbreds.. J Vet Intern Med 2012 Sep-Oct;26(5):1202-8.
            pubmed: 22827474doi: 10.1111/j.1939-1676.2012.00969.xgoogle scholar: lookup
          14. McGurrin MK, Physick-Sheard PW, Kenney DG. Transvenous electrical cardioversion of equine atrial fibrillation: patient factors and clinical results in 72 treatment episodes.. J Vet Intern Med 2008 May-Jun;22(3):609-15.
            pubmed: 18466256doi: 10.1111/j.1939-1676.2008.0081.xgoogle scholar: lookup
          15. Gehlen H, Rohn K, Deegen E, Stadler P. Labordiagnostische Untersuchungen bei Pferden mit Herzerkrankungen: Wertigkeit verschiedener kardialer Marker. Pferdeheilkunde 2006;22:532–541.
          16. Slack JA, McGuirk SM, Erb HN, Lien L, Coombs D, Semrad SD, Riseberg A, Marques F, Darien B, Fallon L, Burns P, Murakami MA, Apple FS, Peek SF. Biochemical markers of cardiac injury in normal, surviving septic, or nonsurviving septic neonatal foals.. J Vet Intern Med 2005 Jul-Aug;19(4):577-80.
            pubmed: 16095177doi: 10.1892/0891-6640(2005)19[577:bmocii]2.0.co;2google scholar: lookup
          17. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay.. Clin Chem 2010 Feb;56(2):254-61.
            pubmed: 19959623doi: 10.1373/clinchem.2009.132654google scholar: lookup
          18. Verheyen T, Decloedt A, van der Vekens N, Sys S, De Clercq D, van Loon G. Ventricular response during lungeing exercise in horses with lone atrial fibrillation.. Equine Vet J 2013 May;45(3):309-14.
            pubmed: 23094848doi: 10.1111/j.2042-3306.2012.00653.xgoogle scholar: lookup
          19. Votion DM, Linden A, Saegerman C, Engels P, Erpicum M, Thiry E, Delguste C, Rouxhet S, Demoulin V, Navet R, Sluse F, Serteyn D, van Galen G, Amory H. History and clinical features of atypical myopathy in horses in Belgium (2000-2005).. J Vet Intern Med 2007 Nov-Dec;21(6):1380-91.
            pubmed: 18196750doi: 10.1892/07-053.1google scholar: lookup
          20. Verheyen T, Decloedt A, De Clercq D, van Loon G. Cardiac changes in horses with atypical myopathy.. J Vet Intern Med 2012 Jul-Aug;26(4):1019-26.
            pubmed: 22646196doi: 10.1111/j.1939-1676.2012.00945.xgoogle scholar: lookup
          21. Young LE, Rogers K, Wood JL. Heart murmurs and valvular regurgitation in thoroughbred racehorses: epidemiology and associations with athletic performance.. J Vet Intern Med 2008 Mar-Apr;22(2):418-26.
            pubmed: 18346144doi: 10.1111/j.1939-1676.2008.0053.xgoogle scholar: lookup
          22. Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges?. Eur Heart J 2012 Mar;33(5):579-86.
            pubmed: 22267244doi: 10.1093/eurheartj/ehr492google scholar: lookup
          23. Van Der Vekens N, Hunter I, Goetze JP. Human and equine cardiovascular biomarkers: beware to compare. Cardiovasc Endocrinol 2013;2:67–76.
          24. Gehlen H, Goltz A, Rohn K, Stadler P. A survey of the frequency and development of heart disease in riding‐horses—Part 1: retrospective evaluation (1992–2003) and questionnaires. Pferdeheilkunde 2007;23:369–377.
          25. Gillis JM, Dunselman P, Jarausch J, de Jong N, Cobbaert CM. Preanalytical storage does not affect 99th percentile cardiac troponin T concentrations measured with a high-sensitivity assay.. Clin Chem 2013 Feb;59(2):442-3.
            pubmed: 23220225doi: 10.1373/clinchem.2012.192211google scholar: lookup
          26. Müller-Bardorff M, Hallermayer K, Schröder A, Ebert C, Borgya A, Gerhardt W, Remppis A, Zehelein J, Katus HA. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation.. Clin Chem 1997 Mar;43(3):458-66.
            pubmed: 9068589
          27. Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB.. Clin Chim Acta 1999 Jun 30;284(2):151-9.
            pubmed: 10451242doi: 10.1016/s0009-8981(99)00077-7google scholar: lookup

          Citations

          This article has been cited 7 times.
          Subscribe to our newsletter
          Join 99,001 horse owners like you who receive our email updates on horse health and nutrition.